Inactive Instrument

YM BioSciences Inc. Share Price

Equities

Duration

Period

Style

YM Biosciences : Raises US$80.5 Million from Public Offering	29/02/12	PU
YM Biosciences : Prices $70 Million Public Offering of Common Shares	24/02/12	PU
YM Biosciences : Announces Proposed Public Offering of Common Shares	23/02/12	PU
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	09/02/12	PU
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	12/12/11	PU

Sector

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+0.17%	42.19B
MODERNA, INC.	+10.92%	42.24B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+5.23%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-24.79%	18.2B
MEDPACE HOLDINGS, INC.	+26.69%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.13%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.57%	10.4B